MediPal Holdings Corporation (FRA:59Z)

Market Cap	2.87B -0.4%
Revenue (ttm)	20.82B +4.0%
Net Income	232.00M +5.6%
EPS	1.13 +7.0%
Shares Out	n/a
PE Ratio	12.38
Forward PE	n/a
Dividend	0.37 (2.63%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	13.80
Previous Close	14.00
Day's Range	13.80 - 14.00
52-Week Range	13.30 - 16.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health product...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1898
• Employees: 13,061
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 59Z

Financial Performance

In fiscal year 2026, MediPal Holdings's revenue was 3.82 trillion, an increase of 3.98% compared to the previous year's 3.67 trillion. Earnings were 42.53 billion, an increase of 5.60%.

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 22, 2026

Data Sources Report a data error